Business

RAMSAY SANTE : Interim results at the end of March 2025

PRESS RELEASE Paris, 14th May 2025 Interim results at the end of March 2025 Activity growth and cost control compensate pricing headwinds Unaudited group revenue for the nine months period ending 31 March 2025 increased by 5.1% to 3.9bn€ supported by activity volume growth and Cosem primary care centres acquired in June 2024. Revenue growth of 3.2% on a like-for-like basis.Unaudited group EBITDA for the nine months period ending 31 March 2025 was almost stable at 441m€, -0.8% or -3.6m€ compared

articleRamsay Generale De Sante SaMay 14, 202514/company/ramsay-generale-de-sante-sa/news/ramsay-sante-interim-results-at-the-end-of-march-2025
RAMSAY SANTE : Interim results at the end of March 2025

About this update from Ramsay Generale De Sante Sa

[{"type":"image","alt":"RAMSAY SANTE","displaySize":"","headline":null,"caption":"RAMSAY SANTE","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":288,"url":"https://media.zenfs.com/en/globenewswire.com/959bad3a6a10a6a66985b8a318e1818f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/OqHn2cm.eQhr7uXoVH6nZw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQwMztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/959bad3a6a10a6a66985b8a318e1818f","width":300,"height":288}},"lazy":false},{"type":"text","content":"PRESS RELEASE                Paris, 14th May 2025","length":130,"tagName":"p"},{"type":"text","content":"Interim results at the end of March 2025","length":40,"tagName":"p"},{"type":"text","content":"Activity growth and cost control compensate pricing headwinds","length":61,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Unaudited group revenue for the nine months period ending 31 March 2025 increased by 5.1% to 3.9bn€ supported by activity volume growth and Cosem primary care centres acquired in June 2024. Revenue growth of 3.2% on a like-for-like basis.","length":238,"tagName":"p"}]},{"val":[{"type":"text","content":"Unaudited group EBITDA for the nine months period ending 31 March 2025 was almost stable at 441m€, -0.8% or -3.6m€ compared to the prior year corresponding period, absorbing most of the impact from the 2024 prudential coefficient in France being withheld by the government, unlike in prior years (14.7m€ last year), much lower subsidies, increasing salaries and procurement inflation which are still under-funded by governments. ","length":428,"tagName":"p"}]},{"val":[{"type":"text","content":"Cost saving efforts (e.g. on agency staff and administrative costs), review of portfolio of facilities and productivity improvements to offset the fall in French revenue guarantee (25m€) and inflation grants (17m€) and a higher inflation on operating costs than on revenue rates.","length":279,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":945,"olType":false},{"type":"text","content":"Low French tariffs continue to weigh on results","length":47,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"French MSO tariff indexation for the 12 months commencing 1st March 2025 has been announced...

More updates from Ramsay Generale De Sante Sa

FranceEBITDAFrench governmentprimary careRevenue growthrevenue guaranteetariff increase